BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35129215)

  • 21. Clinical Characteristics and Prognosis of Peripartum Cardiomyopathy in 28 Patients.
    Liu Y; Zeng Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):78-82. PubMed ID: 26956861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Earlier detection can help avoid many serious complications of peripartum cardiomyopathy.
    Fett JD
    Future Cardiol; 2013 Nov; 9(6):809-16. PubMed ID: 24180539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
    ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial Right Ventricular Dysfunction Severity Identifies Severe Peripartum Cardiomyopathy Phenotype With Worse Early and Overall Outcomes: A 24-Year Cohort Study.
    Peters A; Caroline M; Zhao H; Baldwin MR; Forfia PR; Tsai EJ
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use.
    Pillarisetti J; Kondur A; Alani A; Reddy M; Reddy M; Vacek J; Weiner CP; Ellerbeck E; Schreiber T; Lakkireddy D
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2831-9. PubMed ID: 24814494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry.
    Jackson AM; Bauersachs J; Petrie MC; van der Meer P; Laroche C; Farhan HA; Frogoudaki A; Ibrahim B; Fouad DA; Damasceno A; Karaye K; Goland S; Maggioni AP; Briton O; Sliwa K;
    Eur J Heart Fail; 2024 Jan; 26(1):34-42. PubMed ID: 37823238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
    Trongtorsak A; Kittipibul V; Mahabir S; Ibrahim M; Saint Croix GR; Hernandez GA; Chaparro S
    Heart Fail Rev; 2022 Mar; 27(2):533-543. PubMed ID: 34725781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Prediction for Peripartum Cardiomyopathy in Delivering Mothers: A Validated Risk Model: PPCM Risk Prediction Model.
    Davis MB; Jarvie J; Gambahaya E; Lindenfeld J; Kao D
    J Card Fail; 2021 Feb; 27(2):159-167. PubMed ID: 33388467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.
    Blauwet LA; Delgado-Montero A; Ryo K; Marek JJ; Alharethi R; Mather PJ; Modi K; Sheppard R; Thohan V; Pisarcik J; McNamara DM; Gorcsan J;
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy.
    Hoevelmann J; Viljoen CA; Manning K; Baard J; Hahnle L; Ntsekhe M; Bauersachs J; Sliwa K
    Int J Cardiol; 2019 Feb; 276():177-184. PubMed ID: 30497895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An artificial intelligence electrocardiogram analysis for detecting cardiomyopathy in the peripartum period.
    Lee Y; Choi B; Lee MS; Jin U; Yoon S; Jo YY; Kwon JM
    Int J Cardiol; 2022 Apr; 352():72-77. PubMed ID: 35122911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
    Bauersachs J; König T; van der Meer P; Petrie MC; Hilfiker-Kleiner D; Mbakwem A; Hamdan R; Jackson AM; Forsyth P; de Boer RA; Mueller C; Lyon AR; Lund LH; Piepoli MF; Heymans S; Chioncel O; Anker SD; Ponikowski P; Seferovic PM; Johnson MR; Mebazaa A; Sliwa K
    Eur J Heart Fail; 2019 Jul; 21(7):827-843. PubMed ID: 31243866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features differentiating Takotsubo cardiomyopathy in the peripartum period from peripartum cardiomyopathy.
    Yang WI; Moon JY; Shim M; Yang PS; Kang SH; Kim SH; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH; Ha JW
    Heart Vessels; 2020 May; 35(5):665-671. PubMed ID: 31705186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 12-lead ECG in peripartum cardiomyopathy.
    Tibazarwa K; Lee G; Mayosi B; Carrington M; Stewart S; Sliwa K
    Cardiovasc J Afr; 2012 Jul; 23(6):322-9. PubMed ID: 22337203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).
    McNamara DM; Elkayam U; Alharethi R; Damp J; Hsich E; Ewald G; Modi K; Alexis JD; Ramani GV; Semigran MJ; Haythe J; Markham DW; Marek J; Gorcsan J; Wu WC; Lin Y; Halder I; Pisarcik J; Cooper LT; Fett JD;
    J Am Coll Cardiol; 2015 Aug; 66(8):905-14. PubMed ID: 26293760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.
    Sliwa K; Petrie MC; van der Meer P; Mebazaa A; Hilfiker-Kleiner D; Jackson AM; Maggioni AP; Laroche C; Regitz-Zagrosek V; Schaufelberger M; Tavazzi L; Roos-Hesselink JW; Seferovic P; van Spaendonck-Zwarts K; Mbakwem A; Böhm M; Mouquet F; Pieske B; Johnson MR; Hamdan R; Ponikowski P; Van Veldhuisen DJ; McMurray JJV; Bauersachs J
    Eur Heart J; 2020 Oct; 41(39):3787-3797. PubMed ID: 32840318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden, predictors and short-term outcomes of peripartum cardiomyopathy in a black African cohort.
    Nabbaale J; Okello E; Kibirige D; Ssekitoleko I; Isanga J; Karungi P; Sebatta E; Zhu ZW; Nakimuli A; Omagino J; Kayima J
    PLoS One; 2020; 15(10):e0240837. PubMed ID: 33085703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM).
    Hoevelmann J; Muller E; Azibani F; Kraus S; Cirota J; Briton O; Ntsekhe M; Ntusi NAB; Sliwa K; Viljoen CA
    Clin Res Cardiol; 2021 Aug; 110(8):1259-1269. PubMed ID: 33555408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute kidney injury predicts poor left ventricular function for patients with peripartum cardiomyopathy.
    Zhu J; Liu W
    BMC Cardiovasc Disord; 2021 Apr; 21(1):205. PubMed ID: 33888084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.